Application Information

This drug has been submitted to the FDA under the reference 206646/001.

Names and composition

"DALFAMPRIDINE" is the commercial name of a drug composed of DALFAMPRIDINE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
206646/001 DALFAMPRIDINE DALFAMPRIDINE TABLET, EXTENDED RELEASE/ORAL 10MG
206765/001 DALFAMPRIDINE DALFAMPRIDINE TABLET, EXTENDED RELEASE/ORAL 10MG
206811/001 DALFAMPRIDINE DALFAMPRIDINE TABLET, EXTENDED RELEASE/ORAL 10MG
206836/001 DALFAMPRIDINE DALFAMPRIDINE TABLET, EXTENDED RELEASE/ORAL 10MG
206854/001 DALFAMPRIDINE DALFAMPRIDINE TABLET/ORAL 0.0
206858/001 DALFAMPRIDINE DALFAMPRIDINE TABLET, EXTENDED RELEASE/ORAL 10MG
206863/001 DALFAMPRIDINE DALFAMPRIDINE TABLET, EXTENDED RELEASE/ORAL 10MG
208292/001 DALFAMPRIDINE DALFAMPRIDINE TABLET, EXTENDED RELEASE/ORAL 10MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
022250/001 AMPYRA DALFAMPRIDINE TABLET, EXTENDED RELEASE/ORAL 10MG
206646/001 DALFAMPRIDINE DALFAMPRIDINE TABLET, EXTENDED RELEASE/ORAL 10MG
206765/001 DALFAMPRIDINE DALFAMPRIDINE TABLET, EXTENDED RELEASE/ORAL 10MG
206811/001 DALFAMPRIDINE DALFAMPRIDINE TABLET, EXTENDED RELEASE/ORAL 10MG
206836/001 DALFAMPRIDINE DALFAMPRIDINE TABLET, EXTENDED RELEASE/ORAL 10MG
206854/001 DALFAMPRIDINE DALFAMPRIDINE TABLET/ORAL 0.0
206858/001 DALFAMPRIDINE DALFAMPRIDINE TABLET, EXTENDED RELEASE/ORAL 10MG
206863/001 DALFAMPRIDINE DALFAMPRIDINE TABLET, EXTENDED RELEASE/ORAL 10MG
208292/001 DALFAMPRIDINE DALFAMPRIDINE TABLET, EXTENDED RELEASE/ORAL 10MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved